696O_PR Nivolumab + cabozantinib vs sunitinib in first-line treatment for advanced renal cell carcinoma: First results from the randomized phase III CheckMate 9ER trial

Toni K. Choueiri, Thomas Powles, Mauricio Burotto, María T. Bourlon, Bogdan Żurawski, Víctor Manuel Oyervides-Juárez, James J. Hsieh, Umberto Basso, Amishi Y. Shah, Cristina Suárez, A. Hamzaj, Carlos H. Barrios, Martin Eduardo Richardet, David Pook, Yoshihiko Tomita, Bernard Escudier, J. Zhang, Burçin Şimşek, Andrea B. Apolo, Robert J. Motzer